BACKGROUND AND METHODS. Both the clinical manifestations of cystic fibrosis and the genotypes of patients are heterogeneous, but the associations between the two are not known. We therefore studied blood samples from 293 patients with cystic fibrosis for the presence of the most common disease-causing mutation (delta F508) on chromosome 7 and compared the results with the clinical manifestations of the disease. RESULTS. The prevalence of the delta F508 allele in the cohort was 71 percent; 52 percent of the patients were homozygous for the mutation, 40 percent were heterozygous, and 8 percent had other, undefined mutations. The patients who were homozygous for the mutation had received a diagnosis of cystic fibrosis at an earlier age and had a greater frequency of pancreatic insufficiency; pancreatic insufficiency was present in 99 percent of the homozygous patients, but in 72 percent of the heterozygous patients and only 36 percent of the patients with other genotypes. The patients with pancreatic insufficiency in all three genotype groups had similar clinical characteristics, reflected by an early age at diagnosis, similar sweat chloride values at diagnosis, similar severity of pulmonary disease, and similar percentiles for weight. In contrast, the patients in the heterozygous-genotype and other-genotype groups who did not have pancreatic insufficiency were older and had milder disease. They had lower sweat chloride values at diagnosis, normal nutritional status, and better pulmonary function after adjustment for age. CONCLUSIONS. The variable clinical course in patients with cystic fibrosis can be attributed at least in part to specific genotypes at the locus of the cystic fibrosis gene.
Source Information
Department of Genetics, Hospital for Sick Children, Toronto, ON, Canada.
This article has been cited by other articles:
Mimoun, M., Coste, T. C., Lebacq, J., Lebecque, P., Wallemacq, P., Leal, T., Armand, M.
(2009). Increased Tissue Arachidonic Acid and Reduced Linoleic Acid in a Mouse Model of Cystic Fibrosis Are Reversed by Supplemental Glycerophospholipids Enriched in Docosahexaenoic Acid. J. Nutr.
139: 2358-2364
[Abstract][Full Text]
Bremer, L. A., Blackman, S. M., Vanscoy, L. L., McDougal, K. E., Bowers, A., Naughton, K. M., Cutler, D. J., Cutting, G. R.
(2008). Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet
17: 2228-2237
[Abstract][Full Text]
Cipolli, M., Castellani, C., Wilcken, B., Massie, J., McKay, K., Gruca, M., Tamanini, A., Assael, M. B., Gaskin, K.
(2007). Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening. Arch. Dis. Child.
92: 842-846
[Abstract][Full Text]
Rowe, S. M., Accurso, F., Clancy, J. P.
(2007). Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials. Proc Am Thorac Soc
4: 387-398
[Abstract][Full Text]
Wilschanski, M., Durie, P. R
(2007). Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut
56: 1153-1163
[Full Text]
Vanscoy, L. L., Blackman, S. M., Collaco, J. M., Bowers, A., Lai, T., Naughton, K., Algire, M., McWilliams, R., Beck, S., Hoover-Fong, J., Hamosh, A., Cutler, D., Cutting, G. R.
(2007). Heritability of Lung Disease Severity in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
175: 1036-1043
[Abstract][Full Text]
Figueredo, J., Limberis, M. P., Wilson, J. M.
(2007). Prediction of Cellular Immune Responses against CFTR in Patients with Cystic Fibrosis after Gene Therapy. Am. J. Respir. Cell Mol. Bio.
36: 529-533
[Abstract][Full Text]
Preumont, V., Hermans, M. P., Lebecque, P., Buysschaert, M.
(2007). Glucose Homeostasis and Genotype-Phenotype Interplay in Cystic Fibrosis Patients With CFTR Gene {Delta}F508 Mutation. Diabetes Care
30: 1187-1192
[Abstract][Full Text]
Boyle, M. P.
(2007). Strategies for Identifying Modifier Genes in Cystic Fibrosis. Proc Am Thorac Soc
4: 52-57
[Abstract][Full Text]
McKone, E. F., Goss, C. H., Aitken, M. L.
(2006). CFTR Genotype as a Predictor of Prognosis in Cystic Fibrosis.. Chest
130: 1441-1447
[Abstract][Full Text]
Wilschanski, M., Dupuis, A., Ellis, L., Jarvi, K., Zielenski, J., Tullis, E., Martin, S., Corey, M., Tsui, L.-C., Durie, P.
(2006). Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials. Am. J. Respir. Crit. Care Med.
174: 787-794
[Abstract][Full Text]
Schluchter, M. D., Konstan, M. W., Drumm, M. L., Yankaskas, J. R., Knowles, M. R.
(2006). Classifying Severity of Cystic Fibrosis Lung Disease Using Longitudinal Pulmonary Function Data. Am. J. Respir. Crit. Care Med.
174: 780-786
[Abstract][Full Text]
Wright, J. M., Merlo, C. A., Reynolds, J. B., Zeitlin, P. L., Garcia, J. G. N., Guggino, W. B., Boyle, M. P.
(2006). Respiratory Epithelial Gene Expression in Patients with Mild and Severe Cystic Fibrosis Lung Disease. Am. J. Respir. Cell Mol. Bio.
35: 327-336
[Abstract][Full Text]
McKone, E. F., Shao, J., Frangolias, D. D., Keener, C. L., Shephard, C. A., Farin, F. M., Tonelli, M. R., Pare, P. D., Sandford, A. J., Aitken, M. L., Kavanagh, T. J.
(2006). Variants in the Glutamate-Cysteine-Ligase Gene Are Associated with Cystic Fibrosis Lung Disease. Am. J. Respir. Crit. Care Med.
174: 415-419
[Abstract][Full Text]
Drumm, M. L., Konstan, M. W., Schluchter, M. D., Handler, A., Pace, R., Zou, F., Zariwala, M., Fargo, D., Xu, A., Dunn, J. M., Darrah, R. J., Dorfman, R., Sandford, A. J., Corey, M., Zielenski, J., Durie, P., Goddard, K., Yankaskas, J. R., Wright, F. A., Knowles, M. R., the Gene Modifier Study Group,
(2005). Genetic Modifiers of Lung Disease in Cystic Fibrosis. NEJM
353: 1443-1453
[Abstract][Full Text]
Haston, C. K., Hudson, T. J.
(2005). Finding Genetic Modifiers of Cystic Fibrosis. NEJM
353: 1509-1511
[Full Text]
Jarad, N A, Higgs, S, Jeffcote, T, Giles, K
(2005). Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area. Chronic Respiratory Disease
2: 133-137
[Abstract]
Kraemer, R., Blum, A., Schibler, A., Ammann, R. A., Gallati, S.
(2005). Ventilation Inhomogeneities in Relation to Standard Lung Function in Patients with Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
171: 371-378
[Abstract][Full Text]
Rafii, M., Chapman, K., Stewart, C., Kelly, E., Hanna, A., Wilson, D. C, Tullis, E., Pencharz, P. B
(2005). Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am. J. Clin. Nutr.
81: 421-426
[Abstract][Full Text]
Mikerov, A. N., Umstead, T. M., Huang, W., Liu, W., Phelps, D. S., Floros, J.
(2005). SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol.
288: L150-L158
[Abstract][Full Text]
Decaestecker, K., Decaestecker, E., Castellani, C., Jaspers, M., Cuppens, H., De Boeck, K.
(2004). Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. Eur Respir J
23: 679-684
[Abstract][Full Text]
Boucher, R.C.
(2004). New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J
23: 146-158
[Abstract][Full Text]
Ahmed, N, Corey, M, Forstner, G, Zielenski, J, Tsui, L-C, Ellis, L, Tullis, E, Durie, P
(2003). Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut
52: 1159-1164
[Abstract][Full Text]
Accurso, F. J., Sontag, M. K.
(2003). Seeking Modifier Genes in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
167: 289-290
[Full Text]
Shidrawi, R G, Murugan, N, Westaby, D, Gyi, K, Hodson, M E
(2002). Emergency colonoscopy for distal intestinal obstruction syndrome in cystic fibrosis patients. Gut
51: 285-286
[Full Text]
SELVADURAI, H. C., MCKAY, K. O., BLIMKIE, C. J., COOPER, P. J., MELLIS, C. M., VAN ASPEREN, P. P.
(2002). The Relationship between Genotype and Exercise Tolerance in Children with Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
165: 762-765
[Abstract][Full Text]
Loubieres, Y., Grenet, D., Simon-Bouy, B., Medioni, J., Landais, P., Ferec, C., Stern, M.
(2002). Association Between Genetically Determined Pancreatic Status and Lung Disease in Adult Cystic Fibrosis Patients. Chest
121: 73-80
[Abstract][Full Text]
Evans, A.K.C., Fitzgerald, D.A., McKay, K.O.
(2001). The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J
18: 784-789
[Abstract][Full Text]
Schibler, A., Bolt, I., Gallati, S., Schoni, M.H., Kraemer, R.
(2001). High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and {Delta}F508. Eur Respir J
17: 1181-1186
[Abstract][Full Text]
Gabolde, M, Hubert, D, Guilloud-Bataille, M, Lenaerts, C, Feingold, J, Besmond, C
(2001). The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. J. Med. Genet.
38: 310-311
[Abstract][Full Text]
Mahadeva, R, Sharples, L, Ross-Russell, R I, Webb, A K, Bilton, D, Lomas, D A
(2001). Association of {alpha}1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax
56: 53-58
[Abstract][Full Text]
Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., the Wisconsin Cystic Fibrosis Neonatal Screening S,
(2001). Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth. Pediatrics
107: 1-13
[Abstract][Full Text]
Desmarquest, P., Feldmann, D., Tamalat, A., Boule, M., Fauroux, B., Tournier, G., Clement, A.
(2000). Genotype Analysis and Phenotypic Manifestations of Children With Intermediate Sweat Chloride Test Results. Chest
118: 1591-1597
[Abstract][Full Text]
BOYNE, J., EVANS, S., POLLITT, R. J, TAYLOR, C. J, DALTON, A.
(2000). Many Delta F508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation. J. Med. Genet.
37: 543-547
[Full Text]
Parad, R. B., Gerard, C. J., Zurakowski, D., Nichols, D. P., Pier, G. B.
(1999). Pulmonary Outcome in Cystic Fibrosis Is Influenced Primarily by Mucoid Pseudomonas aeruginosa Infection and Immune Status and Only Modestly by Genotype. Infect. Immun.
67: 4744-4750
[Abstract][Full Text]
Dohle, G.R., Veeze, H.J., Overbeek, S.E., van den Ouweland, A.M.W., Halley, D.J.J., Weber, R.F.A., Niermeijer, M.F.
(1999). The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data. Hum Reprod
14: 371-374
[Abstract][Full Text]
Ostedgaard, L., Zeiher, B, Welsh, M.
(1999). Processing of CFTR bearing the P574H mutation differs from wild-type and deltaF508-CFTR. J. Cell Sci.
112: 2091-2098
[Abstract]
QUINTON, P. M.
(1999). Physiological Basis of Cystic Fibrosis: A Historical Perspective. Physiol. Rev.
79: 3-22
[Abstract][Full Text]
Wilschanski, M., Rivlin, J., Cohen, S., Augarten, A., Blau, H., Aviram, M., Bentur, L., Springer, C., Vila, Y., Branski, D., Kerem, B., Kerem, E.
(1999). Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease. Pediatrics
103: 52-57
[Abstract][Full Text]
Hull, J., Thomson, A. H
(1998). Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax
53: 1018-1021
[Abstract][Full Text]
Pier, G. B., Grout, M., Zaidi, T. S.
(1997). Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA
94: 12088-12093
[Abstract][Full Text]
Kerem, E., Nissim-Rafinia, M., Argaman, Z., Augarten, A., Bentur, L., Klar, A., Yahav, Y., Szeinberg, A., Hiba, O., Branski, D., Corey, M., Kerem, B.
(1997). A Missense Cystic Fibrosis Transmembrane Conductance Regulator Mutation With Variable Phenotype. Pediatrics
100: e5-e5
[Abstract][Full Text]
Kingdom, T. T., Lee, K. C., Fitz Simmons, S. C., Cropp, G. J.
(1996). Clinical Characteristics and Genotype Analysis of Patients With Cystic Fibrosis and Nasal Polyposis Requiring Surgery. Arch Otolaryngol Head Neck Surg
122: 1209-1213
[Abstract]
Gan, K.-H., Veeze, H. J., van den Ouweland, A., Halley, D., Scheffer, H., van der Hout, A., Overbeek, S. E., de Jongste, J. C., Bakker, W., Heijerman, H.
(1995). A Cystic Fibrosis Mutation Associated with Mild Lung Disease. NEJM
333: 95-99
[Abstract][Full Text]
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., Boucher, R. C., Knowles, M. R.
(1994). A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations. NEJM
331: 974-980
[Abstract][Full Text]
Ranieri, E, Lewis, B D, Gerace, R L, Ryall, R G, Morris, C P, Nelson, P V, Carey, W F, Robertson, E F
(1994). Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience. BMJ
308: 1469-1472
[Abstract][Full Text]
Gan, K.H., Heijerman, H.G.M., Bakker, W., Augarten, A., Kerem, B.-S., Kerem, E., Gazit, E., Yahav, Y., Hamosh, A., Corey, M.
(1994). Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis. NEJM
330: 865-867
[Full Text]
The Cystic Fibrosis Genotype-Phenotype Consortium,
(1993). Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis. NEJM
329: 1308-1313
[Abstract][Full Text]
Board, A.S.P.E.N.
(1993). Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. JPEN J Parenter Enteral Nutr
17: 1SA-52SA
WRIGHT, N. M., METZGER, D. L., BOROWITZ, S. M., CLARKE, W. L.
(1993). Permanent Neonatal Diabetes Mellitus and Pancreatic Exocrine Insufficiency Resulting From Congenital Pancreatic Agenesis. Arch Pediatr Adolesc Med
147: 607-609
[Abstract]
Collins, F.
(1992). Cystic fibrosis: molecular biology and therapeutic implications. Science
256: 774-779
[Abstract]
Anguiano, A., Oates, R. D., Amos, J. A., Dean, M., Gerrard, B., Stewart, C., Maher, T. A., White, M. B., Milunsky, A.
(1992). Congenital Bilateral Absence of the Vas Deferens: A Primarily Genital Form of Cystic Fibrosis. JAMA
267: 1794-1797
[Abstract]
Drumm, M., Wilkinson, D., Smit, L., Worrell, R., Strong, T., Frizzell, R., Dawson, D., Collins, F.
(1991). Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science
254: 1797-1799
[Abstract]
Rich, D., Gregory, R., Anderson, M., Manavalan, P, Smith, A., Welsh, M.
(1991). Effect of deleting the R domain on CFTR-generated chloride channels. Science
253: 205-207
[Abstract]
Previous
